• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌筛查对特定年龄人群发病率的影响:来自瑞典准实验研究的证据。

Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden.

机构信息

School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, PO Box 469, 405 30, Gothenburg, Sweden.

Department of Medicine K2, Solna, 171 76, Stockholm, Karolinska Institutet, Sweden.

出版信息

Eur J Epidemiol. 2024 Jan;39(1):87-96. doi: 10.1007/s10654-023-01073-6. Epub 2024 Jan 4.

DOI:10.1007/s10654-023-01073-6
PMID:38177571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10810926/
Abstract

Colorectal cancer (CRC) incurs a significant disease burden globally. Organised CRC screening programmes have been widely implemented for early detection and prevention. To understand the public health impact of these programmes, quantitative evidence of changes in overall and age-specific population incidences is fundamental. We aimed to provide such evidence by exploiting a time lag in the implementation of organised screening in Sweden: two out of 21 regions (these two regions comprise nearly 20% of the total Swedish population) have offered organised screening since 2008; the other regions have offered CRC screening since 2021. Using registry data on diagnosed CRC cases and socio-demographics for all regions in Sweden over the period 1970-2019, Bayesian structural time series modelling and difference-in-differences were applied to analyse the impact of screening on age-specific population incidences over time (CRC cases per 100.000 persons/year). After inviting birth-year cohorts aged 60-69 years for stool-based testing, the incidence rate in the 70-74-year age group decreased significantly over time, with an average reduction of - 44·40 (95% CI - 58·15 to - 31·31) from 2011 to 2019 in the intervention regions. In the overall population aged 60-74 years, there was a net incidence decrease of - 7·99 (95% CI - 13·85 to - 2·39) since the initiation of organised screening in the intervention regions (2008-2019). Organised CRC screening for 60-69-year-olds generated a change in age-specific incidence patterns with a long-lasting incidence decrease in the 70-74-year-old population, implying reductions in the excess mortality and burden of the disease.

摘要

结直肠癌(CRC)在全球造成了巨大的疾病负担。有组织的 CRC 筛查计划已广泛实施,以进行早期发现和预防。为了了解这些计划对公共卫生的影响,基本需要定量证据来证明总体和年龄特定人群发病率的变化。我们旨在通过利用瑞典实施有组织筛查的时间差来提供这种证据:21 个地区中的两个(这两个地区占瑞典总人口的近 20%)自 2008 年以来提供了有组织的筛查;其他地区自 2021 年以来提供 CRC 筛查。利用瑞典所有地区 1970 年至 2019 年期间诊断为 CRC 的病例和社会人口统计学的登记数据,我们应用贝叶斯结构时间序列模型和差分分析来分析筛查对随时间推移的年龄特定人群发病率的影响(每 100.000 人/年的 CRC 病例数)。在邀请 60-69 岁的出生年份队列进行基于粪便的检测后,70-74 岁年龄组的发病率随着时间的推移显著下降,在干预地区,2011 年至 2019 年期间的平均降幅为 -44.40(95%CI-58.15 至-31.31)。在 60-74 岁的总体人群中,自干预地区开展有组织的筛查以来(2008-2019 年),总体发病率净下降了-7.99(95%CI-13.85 至-2.39)。60-69 岁人群的结直肠癌有组织筛查导致了年龄特定发病率模式的变化,70-74 岁人群的发病率持续下降,这意味着疾病的超额死亡率和负担有所减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159a/10810926/841d149947d1/10654_2023_1073_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159a/10810926/1f2e09626c20/10654_2023_1073_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159a/10810926/841d149947d1/10654_2023_1073_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159a/10810926/1f2e09626c20/10654_2023_1073_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159a/10810926/841d149947d1/10654_2023_1073_Fig2_HTML.jpg

相似文献

1
Impact of organised colorectal cancer screening on age-specific population incidences: evidence from a quasi-experimental study in Sweden.结直肠癌筛查对特定年龄人群发病率的影响:来自瑞典准实验研究的证据。
Eur J Epidemiol. 2024 Jan;39(1):87-96. doi: 10.1007/s10654-023-01073-6. Epub 2024 Jan 4.
2
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.粪便免疫化学试验筛查近端和远端结直肠癌的长期效果。
Gut. 2021 Dec;70(12):2321-2329. doi: 10.1136/gutjnl-2020-322545. Epub 2021 Jan 25.
3
Colon Cancer Screening - Is It Time Yet?结肠癌筛查——是时候了吗?
J Coll Physicians Surg Pak. 2017 Jun;27(6):327-328.
4
Sociodemographic changes in the population frequency of colonoscopy following the implementation of organised bowel cancer screening: An analysis of data from Swedish registers, 2006-2015.人口统计学变化对结直肠癌筛查后结肠镜检查人群频率的影响:基于瑞典登记数据的分析,2006-2015 年。
J Med Screen. 2021 Sep;28(3):244-251. doi: 10.1177/0969141320957708. Epub 2020 Sep 22.
5
Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.基于人群筛查建议后50岁及以上人群结直肠癌发病率的下降
Clin Gastroenterol Hepatol. 2017 Jun;15(6):903-909.e6. doi: 10.1016/j.cgh.2016.08.037. Epub 2016 Sep 5.
6
Colorectal cancer screening: a global overview of existing programmes.结直肠癌筛查:现有项目的全球概览。
Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3.
7
Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study.糖尿病患者结直肠癌发病风险:一项瑞典全国性队列研究。
PLoS Med. 2020 Nov 13;17(11):e1003431. doi: 10.1371/journal.pmed.1003431. eCollection 2020 Nov.
8
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.荷兰基于粪便免疫化学检测的筛查计划实施前后的结直肠癌发病率、死亡率、肿瘤特征及治疗情况:一项基于人群的研究
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):60-68. doi: 10.1016/S2468-1253(21)00368-X. Epub 2021 Nov 22.
9
Rational targeting of population groups and residential areas for colorectal cancer screening.针对结直肠癌筛查的目标人群和目标地区进行合理定位。
Cancer Epidemiol. 2019 Jun;60:23-30. doi: 10.1016/j.canep.2019.01.009. Epub 2019 Mar 18.
10
The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.45 岁及以上商业和医疗保险人群非侵入性基于粪便的结直肠癌筛查产品的成本效益。
J Med Econ. 2023 Jan-Dec;26(1):1219-1226. doi: 10.1080/13696998.2023.2260681. Epub 2023 Oct 6.

引用本文的文献

1
MicroRNAs in the Diagnosis of Digestive Diseases: A Comprehensive Review.微小RNA在消化系统疾病诊断中的应用:综述
J Clin Med. 2025 Mar 18;14(6):2054. doi: 10.3390/jcm14062054.
2
Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield.粪便免疫化学检测或结肠镜初筛用于结直肠癌筛查:诊断效能的差异。
JNCI Cancer Spectr. 2024 Apr 30;8(3). doi: 10.1093/jncics/pkae043.
3
Prognostic significance of a signature based on senescence-related genes in colorectal cancer.基于衰老相关基因的特征在结直肠癌中的预后意义。

本文引用的文献

1
[Screening for colorectal cancer nationally instituted in Sweden].
Lakartidningen. 2023 Jun 13;120:23026.
2
Controversy over colonoscopy for colorectal cancer screening.关于结肠镜检查用于结直肠癌筛查的争议。
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1061. doi: 10.1016/S2468-1253(22)00356-9. Epub 2022 Oct 26.
3
Understanding the Results of a Randomized Trial of Screening Colonoscopy.解读结肠镜筛查随机试验的结果
N Engl J Med. 2022 Oct 27;387(17):1609-1611. doi: 10.1056/NEJMe2211595. Epub 2022 Oct 9.
Geroscience. 2024 Oct;46(5):4495-4504. doi: 10.1007/s11357-024-01164-6. Epub 2024 Apr 25.
4
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.结肠镜筛查对结直肠癌发病风险和相关死亡的影响。
N Engl J Med. 2022 Oct 27;387(17):1547-1556. doi: 10.1056/NEJMoa2208375. Epub 2022 Oct 9.
5
Effectiveness of population-based colorectal cancer screening programme in down-staging.基于人群的结直肠癌筛查计划在降期方面的效果。
Cancer Epidemiol. 2022 Aug;79:102184. doi: 10.1016/j.canep.2022.102184. Epub 2022 May 14.
6
Characteristics of colorectal cancers among Alaska Native people before and after implementing programs to promote screening.阿拉斯加原住民实施筛查促进项目前后的结直肠癌特征。
J Cancer Policy. 2021 Sep;29:100293. doi: 10.1016/j.jcpo.2021.100293. Epub 2021 Jul 12.
7
How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study.粪便免疫化学试验筛查项目如何改变年度结直肠癌发病率:一项意大利意向筛查研究。
Br J Cancer. 2022 Aug;127(3):541-548. doi: 10.1038/s41416-022-01813-7. Epub 2022 Apr 20.
8
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家结直肠癌及其危险因素负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647. doi: 10.1016/S2468-1253(22)00044-9. Epub 2022 Apr 7.
9
Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.一次性结肠镜检查或每两年进行两轮粪便免疫化学检测用于结直肠癌筛查(SCREESCO):一项随机对照试验的初步报告
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):513-521. doi: 10.1016/S2468-1253(21)00473-8. Epub 2022 Mar 14.
10
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.2010 年至 2019 年 29 种癌症的发病率、死亡率、生命损失年数、失能生存年数和伤残调整生命年:2019 年全球疾病负担研究的系统分析。
JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.